Lista de obras - Nabarun Dasgupta - Dominio Público Uruguay

8th European Conference on Rare Diseases & Orphan Products (ECRD 2016): Edinburgh, UK. 26-28 May 2016.

artículo científico publicado en 2016

A statewide evaluation of seven strategies to reduce opioid overdose in North Carolina.

artículo científico publicado en 2017

Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology

artículo científico publicado en 2021

An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study

artículo científico publicado en 2019

An analysis of the root causes for opioid-related overdose deaths in the United States.

artículo científico publicado en 2011

Association between non-medical and prescriptive usage of opioids

artículo científico publicado en 2005

Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data

artículo científico publicado en 2020

Author Correction: Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts

article

Authors’ Response to Silverman and Colleagues’ Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”

artículo científico publicado en 2018

Breaking the news or fueling the epidemic? Temporal association between news media report volume and opioid-related mortality

artículo científico publicado en 2009

Chronic pain, addiction severity, and misuse of opioids in Cumberland County, Maine.

artículo científico publicado en 2011

Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality

artículo científico publicado en 2015

Commentary on Degenhardt et al (2015): a new formulation for research.

artículo científico publicado en 2015

Commentary van der Gouwe et al. (2017): Drug-testing services and cryptomarkets come of age.

artículo científico publicado en 2017

Comparing Unintentional Opioid Poisoning Mortality in Metropolitan and Non-Metropolitan Counties, United States, 1999–2003

Concerns about injectable naltrexone for opioid dependence

artículo científico publicado en 2011

Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence

article

Crowdsourcing black market prices for prescription opioids

artículo científico publicado en 2013

Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses

artículo científico publicado en 2014

Digital drug safety surveillance: monitoring pharmaceutical products in twitter

artículo científico publicado en 2014

Diversion and Illicit Sale of Extended Release Tapentadol in the United States

artículo científico publicado en 2015

Eight principles for safer opioid prescribing and cautions with benzodiazepines

artículo científico publicado en 2014

Epidemiology of stimulant misuse and abuse: implications for future epidemiologic and neuropharmacologic research.

artículo científico publicado en 2014

Ethics in a pandemic: a survey of the state pandemic influenza plans.

artículo científico publicado en 2007

Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts

artículo científico publicado en 2017

Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011

artículo científico publicado en 2014

Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts

article

Illicit use of opioids: is OxyContin a "gateway drug"?

artículo científico publicado en 2007

Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012.

artículo científico publicado en 2015

Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.

artículo científico publicado en 2015

Injectable extended-release naltrexone for opioid dependence – Authors' reply

artículo científico publicado en 2011

Interpreting Poison Center Call Volume Associated with Tramadol

scientific article published on 08 March 2011

Observed transition from opioid analgesic deaths toward heroin

artículo científico publicado en 2014

Obtaining adequate data to determine causes of opioid-related overdose deaths

artículo científico publicado en 2011

Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids

artículo científico publicado en 2018

Post-marketing surveillance of methadone and buprenorphine in the United States

artículo científico publicado en 2010

Prescription histories and dose strengths associated with overdose deaths

artículo científico publicado en 2014

Quantifying the social distancing privilege gap: a longitudinal study of smartphone movement

artículo científico publicado en 2020

Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users

artículo científico publicado en 2011

Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.

artículo científico publicado en 2018

Signal detection in post-marketing surveillance for controlled substances.

scientific article published on 18 July 2009

Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains.

artículo científico publicado en 2017

Social Media Listening for Routine Post-Marketing Safety Surveillance

artículo científico

Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.

artículo científico publicado en 2013

Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.

artículo científico publicado en 2016

The street prices of immediate- and extended-release tapentadol are lower than other schedule II opioid tablets/capsules

scholarly article by M.C. Le Lait et al published January 2015 in Drug and Alcohol Dependence

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

artículo científico publicado en 2017

Using poison center exposure calls to predict methadone poisoning deaths

artículo científico publicado en 2012

When drugs in the same controlled substance schedule differ in real-world abuse, should they be differentiated in labeling?

artículo científico publicado en 2011

Lista de obras de Nabarun Dasgupta

8th European Conference on Rare Diseases & Orphan Products (ECRD 2016): Edinburgh, UK. 26-28 May 2016.

A statewide evaluation of seven strategies to reduce opioid overdose in North Carolina.

Abuse-Deterrent Opioids: A Survey of Physician Beliefs, Behaviors, and Psychology

An Online Survey for Pharmacoepidemiological Investigation (Survey of Non-Medical Use of Prescription Drugs Program): Validation Study

An analysis of the root causes for opioid-related overdose deaths in the United States.

Association between non-medical and prescriptive usage of opioids

Association between opioid analgesic therapy and initiation of buprenorphine management: An analysis of prescription drug monitoring program data

Author Correction: Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts

Authors’ Response to Silverman and Colleagues’ Comment on “Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence”

Breaking the news or fueling the epidemic? Temporal association between news media report volume and opioid-related mortality

Chronic pain, addiction severity, and misuse of opioids in Cumberland County, Maine.

Cohort Study of the Impact of High-Dose Opioid Analgesics on Overdose Mortality

Commentary on Degenhardt et al (2015): a new formulation for research.

Commentary van der Gouwe et al. (2017): Drug-testing services and cryptomarkets come of age.

Comparing Unintentional Opioid Poisoning Mortality in Metropolitan and Non-Metropolitan Counties, United States, 1999–2003

Concerns about injectable naltrexone for opioid dependence

Correction to: Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence

Crowdsourcing black market prices for prescription opioids

Differential prescribing of opioid analgesics according to physician specialty for Medicaid patients with chronic noncancer pain diagnoses

Digital drug safety surveillance: monitoring pharmaceutical products in twitter

Diversion and Illicit Sale of Extended Release Tapentadol in the United States

Eight principles for safer opioid prescribing and cautions with benzodiazepines

Epidemiology of stimulant misuse and abuse: implications for future epidemiologic and neuropharmacologic research.

Ethics in a pandemic: a survey of the state pandemic influenza plans.

Evaluation of Facebook and Twitter Monitoring to Detect Safety Signals for Medical Products: An Analysis of Recent FDA Safety Alerts

Evolution and convergence of state laws governing controlled substance prescription monitoring programs, 1998-2011

Frequent discussion of insomnia and weight gain with glucocorticoid therapy: an analysis of Twitter posts

Illicit use of opioids: is OxyContin a "gateway drug"?

Incidence of opioid-managed pelvic pain after hysteroscopic sterilization versus laparoscopic sterilization, US 2005-2012.

Increasing Patient Engagement in Pharmacovigilance Through Online Community Outreach and Mobile Reporting Applications: An Analysis of Adverse Event Reporting for the Essure Device in the US.

Injectable extended-release naltrexone for opioid dependence – Authors' reply

Interpreting Poison Center Call Volume Associated with Tramadol

Observed transition from opioid analgesic deaths toward heroin

Obtaining adequate data to determine causes of opioid-related overdose deaths

Opioid tolerance and clinically recognized opioid poisoning among patients prescribed extended-release long-acting opioids

Post-marketing surveillance of methadone and buprenorphine in the United States

Prescription histories and dose strengths associated with overdose deaths

Quantifying the social distancing privilege gap: a longitudinal study of smartphone movement

Reducing harm from injecting pharmaceutical tablet or capsule material by injecting drug users

Review of Case Narratives from Fatal Overdoses Associated with Injectable Naltrexone for Opioid Dependence.

Signal detection in post-marketing surveillance for controlled substances.

Silicon to syringe: Cryptomarkets and disruptive innovation in opioid supply chains.

Social Media Listening for Routine Post-Marketing Safety Surveillance

Surveillance of diversion and nonmedical use of extended-release prescription amphetamine and oral methylphenidate in the United States.

Sustained reduction of diversion and abuse after introduction of an abuse deterrent formulation of extended release oxycodone.

The street prices of immediate- and extended-release tapentadol are lower than other schedule II opioid tablets/capsules

Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bupropion: A Content Analysis.

Using poison center exposure calls to predict methadone poisoning deaths

When drugs in the same controlled substance schedule differ in real-world abuse, should they be differentiated in labeling?